RUNX1 expression has been shown to be regulated by AR in human prostate cancer and triple negative breast cancer cells in vitro [46, 47] and ReMap ChIP-seq data reveals AR binding sites on mouse Runx1 and -2 promoter and intronic areas. The gene discussed is AR; the disease is triple-negative breast carcinoma.